191 related articles for article (PubMed ID: 34617994)
1. Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings.
Pinto MV; Laughlin RS; Klein CJ; Mandrekar J; Naddaf E
Rheumatology (Oxford); 2022 May; 61(6):2504-2511. PubMed ID: 34617994
[TBL] [Abstract][Full Text] [Related]
2. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes.
Alamr M; Pinto MV; Naddaf E
Muscle Nerve; 2022 Dec; 66(6):686-693. PubMed ID: 36052422
[TBL] [Abstract][Full Text] [Related]
3. Sporadic Inclusion Body Myositis: A Clinicopathological Study.
Challa S; Jakati S; Narla S; Uppin MS; Kannan MA; Jagarlapudi MKM
Neurol India; 2021; 69(3):638-641. PubMed ID: 34169859
[TBL] [Abstract][Full Text] [Related]
4. Inclusion body myositis (IBM).
Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
[TBL] [Abstract][Full Text] [Related]
5. [Inclusion body myositis (IBM) -- a review].
Czaplinski A; Renaud S; Fuhr P
Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
[TBL] [Abstract][Full Text] [Related]
6. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.
Brady S; Squier W; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699
[TBL] [Abstract][Full Text] [Related]
7. Electromyography varies by stage in inclusion body myositis.
Mano T; Iguchi N; Eura N; Iwasa N; Yamada N; Horikawa H; Sugie K
Front Neurol; 2023; 14():1295396. PubMed ID: 38249752
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of dysphagic inclusion body myositis.
Taira K; Mori-Yoshimura M; Yamamoto T; Oya Y; Nishino I; Takahashi Y
Neuromuscul Disord; 2023 Feb; 33(2):133-138. PubMed ID: 36575104
[TBL] [Abstract][Full Text] [Related]
9. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.
Michelle EH; Pinal-Fernandez I; Casal-Dominguez M; Albayda J; Paik JJ; Tiniakou E; Adler B; Mecoli CA; Danoff SK; Christopher-Stine L; Mammen AL; Lloyd TE
Neurology; 2023 Mar; 100(13):e1406-e1417. PubMed ID: 36690456
[TBL] [Abstract][Full Text] [Related]
10. [Dysphagia as the only manifestation of inclusion body myositis].
Olivé M; Villanueva P; Ferrer I; Montero J; Martínez-Matos JA
Neurologia; 1994 May; 9(5):202-3. PubMed ID: 8024828
[TBL] [Abstract][Full Text] [Related]
11. Correlations of disease severity outcome measures in inclusion body myositis.
Goyal NA; Greenberg SA; Cauchi J; Araujo N; Li V; Wencel M; Irani T; Wang LH; Palma AM; Villalta SA; Mozaffar T
Neuromuscul Disord; 2022 Oct; 32(10):800-805. PubMed ID: 36050251
[TBL] [Abstract][Full Text] [Related]
12. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled.
van de Vlekkert J; Hoogendijk JE; de Visser M
Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837
[TBL] [Abstract][Full Text] [Related]
13. Inclusion-body myositis presenting with facial diplegia.
Ghosh PS; Laughlin RS; Engel AG
Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039
[TBL] [Abstract][Full Text] [Related]
14. Inclusion body myositis. Observations in 40 patients.
Lotz BP; Engel AG; Nishino H; Stevens JC; Litchy WJ
Brain; 1989 Jun; 112 ( Pt 3)():727-47. PubMed ID: 2543478
[TBL] [Abstract][Full Text] [Related]
15. Inclusion body myositis with early onset: a population-based study.
Lindgren U; Hedberg-Oldfors C; Pullerits R; Lindberg C; Oldfors A
J Neurol; 2023 Nov; 270(11):5483-5492. PubMed ID: 37498322
[TBL] [Abstract][Full Text] [Related]
16. [Electromyographic aspects of inclusion body myositis. Macro-electromyographic study].
Pouget J; Pellissier JF; Serratrice G
Rev Electroencephalogr Neurophysiol Clin; 1987 Sep; 17(3):319-28. PubMed ID: 2825303
[TBL] [Abstract][Full Text] [Related]
17. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Curr Neurol Neurosci Rep; 2013 Jan; 13(1):321. PubMed ID: 23250766
[TBL] [Abstract][Full Text] [Related]
18. Inclusion body myositis: clinical and histopathological features of 36 patients.
Beyenburg S; Zierz S; Jerusalem F
Clin Investig; 1993 May; 71(5):351-61. PubMed ID: 8389626
[TBL] [Abstract][Full Text] [Related]
19. Anti-cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis.
Paul P; Liewluck T; Ernste FC; Mandrekar J; Milone M
Muscle Nerve; 2021 Apr; 63(4):490-496. PubMed ID: 33373040
[TBL] [Abstract][Full Text] [Related]
20. Electromyographs of the flexor digitorum profundus muscle are useful for the diagnosis of inclusion body myositis.
Hokkoku K; Sonoo M; Higashihara M; Stålberg E; Shimizu T
Muscle Nerve; 2012 Aug; 46(2):181-6. PubMed ID: 22806366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
